The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Tue., Aug. 4, 6:31 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #26. Eli Lilly and Company Novartis Animal Health

Acquirer: Eli Lilly and Company (NYSE:LLY)
Acquiree: Novartis Animal Health
Details: Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that will strengthen and diversify Lilly's own animal health business, Elanco. Upon completion of the acquisition, Elanco will be the second-largest animal health company in terms of global revenue, will solidify its number two ranking in the U.S., and improve its position in Europe and the rest of the world.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s human pharmaceutical products include: diabetes and other endocrinology products, immunology products, neuroscience products, oncology products, and other products. Co.'s diabetes and other endocrinology products include: Baqsimi® and Basaglar®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta® and Emgality®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux® and Verzenio®. Co.'s other products include: Cialis®.

Eli Lilly SEC Filing Email Alerts Service

Open the LLY Page at The Online Investor »

Company Name:  Lilly (Eli) & Co
Stock buyback:  LLY buyback
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding LLY:  117
Total Market Value Held by ETFs:  $14.27B
Total Market Capitalization:  $146.33B
% of Market Cap. Held by ETFs:  9.75%

Open the LLY Page at The Online Investor (in a new window) »

August 4, 2020    6:31 AM Eastern
Quotes delayed 20 minutes

Buy (3.40 out of 4)
59th percentile
(ranked higher than approx. 59% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 26 of 100 | | Copyright © 1998 - 2020, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.